04/23/2024
1:59 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Emerald Bioventures, LLC (Filed by)
| Form SC 13G | |
04/09/2024
3:58 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/28/2024
5:26 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
5:08 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:13 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
3:36 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A | |
12/28/2023
4:05 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/07/2023
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
11/16/2023
6:15 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:21 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
6:21 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
3:01 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEF 14A | |
10/19/2023
3:06 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
10/19/2023
3:15 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form ARS | |
09/26/2023
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
8:12 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
6:10 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
6:22 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
3:23 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
4:26 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 424B5 | |
08/07/2023
4:27 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/21/2023
7:25 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
7:22 AM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Caissa Capital Management ltd. (Filed by)
| Form SC 13G/A | |
06/28/2023
5:12 PM | Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Boyd Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
3:10 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Caissa Capital Management ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:14 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Caissa Capital Management ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:39 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:41 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Sullivan Christopher Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:05 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
3:15 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Caissa Capital Management ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
6:43 AM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
6:44 AM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Sullivan Christopher Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
4:23 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Caissa Capital Management ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:10 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/02/2023
11:15 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form EFFECT | |
04/27/2023
11:15 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form EFFECT | |
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad) Don't Buy Bullion or Mining Stocks. Do THIS Instead
As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. |
04/24/2023
3:32 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Caissa Capital Management ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
